Bio-Techne (TECH) said Thursday it has entered into a strategic co-marketing and co-promotion agreement with Waters Corporation (WAT) to expand the reach of biotherapeutic characterization and development processes.
The companies plan to merge Bio-Techne's MauriceFlex System for charge separation with Waters' BioAccord LC-MS System for liquid chromatography mass spectrometry to provide solutions to optimize workflows, improve precision, and accelerate development timelines, the firm said.
Price: 70.62, Change: -0.79, Percent Change: -1.11
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。